6–11yrs: max 2.5mg (5mL) once daily in the PM. ≥12yrs: 2.5–5mg (5–10mL) once daily in the PM based on symptom severity. Max: 5mg/day. Drowsiness; allergic reaction (discontinue if occurs).
has completed the acquisition of global biopharmaceutical company UCB's mature neurology and allergy business in China, in partnership with Mubadala Investment Company, an Abu Dhabi global investment ...
The deal encompasses UCB's Zhuhai manufacturing site and its brands Xyzal, Keppra ... "CBC acquires UCB’s neurology and allergy business in China" was originally created and published by ...